tiprankstipranks
Omega Therapeutics reports Q3 revenue $2.61M, consensus $1.34M
The Fly

Omega Therapeutics reports Q3 revenue $2.61M, consensus $1.34M

As of September 30, the company had cash and cash equivalents totaling $30.4M, which is expected to fund operations into Q2 2025.

Invest with Confidence:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles